Aptar Pharma to exhibit latest innovations in drug delivery devices at Pharm2019

Located at booth B42, Hall 7.2, Aptar Pharma will present their diverse portfolio of drug delivery systems, components and active packaging solutions, including their latest innovations across nasal, pulmonary, eye care, injectables and dermal drug delivery routes:
PureHale - their recently launched, portable and ready-to-use device designed to deliver natural care to upper airways
their expanded range of connected drug delivery devices designed to help increase dose adherence and improve patient health outcomes
Aptar Pharma Services, a portfolio of stage-specific development packages to help customers accelerate their development journey from molecule to market
Active packaging solutions from Aptar CSP Technologies, now part of the Aptar family. Aptar CSP Technologies offers a variety of innovative active packaging solutions to help optimize your drug product’s packaging environment.
Considered to be Europe's dedicated pharmaceutical packaging and drug delivery event, Pharmapack provides invaluable insight into and recognition of the latest trends, developments and regulatory changes impacting the industry, as well as a wide variety of learning opportunities.
As part of the Innovation Gallery at Pharmapack this year, Aptar Pharma will showcase two of their newest product launches, PureHale and QuickStart Injectables – their Ready-to-Use drug development support packages designed to accelerate time-to-market for research and development labs.
Both innovations are contenders for the Pharmapack 2019 Awards, which will be announced during the show.
With more than 400 exhibitors and more than 5000 pharma & drug delivery professionals expected to attend Pharmapack this year, Aptar Pharma welcomes the opportunity to meet with their customers and partners from around the world at this key industry event.
Sign up for your free email newsletter
Visit Aptar Pharma at booth B42, Hall 7.2, where their team of experts will be on hand to demonstrate their technologies and discuss ways they can partner with customers to ensure their drug delivery challenges are met.
Looking for chemical products? Let suppliers reach out to you!
2026-07-15
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India’s API Trade Balance Turns Positive
-
BioNTech’s Founders Turn the Page
-
Novo Nordisk Faces a Compliance Test
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
Minoxidil Safety Under Global Review as Infant Exposure Risks Surface
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
Substandard Drug Findings Expose Deep Structural Gaps in Medicine Quality Control
-
Novo Nordisk Sounds the Alarm: Growth Headwinds Loom Over Global Operations in 2026
-
Obesity Drugs Become Pharma’s Most Powerful Growth Engine
-
Indian Immunologicals Pushes Back on “Fake Vaccine” Claims Amid Global Supply Chain Scrutiny
Recommend Reading
-
Trump Warns of 200 Percent Tariffs on Pharma Companies by August 1 India Trade Deal Among Top Priorities
-
Emcure Seals Exclusive Deal for Sanofi’s Oral Diabetes Brands Millions of Indian Patients to Benefit
-
AstraZeneca Rare Disease Drug Misses Phase 3 Target Hope Shifts to Subgroup Data
-
Over 22,000 New Cases in India AstraZeneca Gets CDSCO Green Light for Muscle-Invasive Bladder Cancer Drug
-
60 Percent Workforce Held by Top 10 Firms! China’s TCM Industry Faces Fierce Reshuffle as Private Leaders Expand Fast
-
Rate of Change Turns Negative—Retail Prices for Refined Oil Products to Be Lowered This Round
-
Post-holiday Isobutanol Prices Rebound
-
Polyvantis Opens Shanghai Technical Center
-
Sherwin-Williams Completes Acquisition of BASF's Decorative Paints Business in Brazil for $1.15 Billion
-
Supply Contraction Keeps Raw Materials Firm; PP Market Prices Remain High and Continue to Rise